Biotech New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions December 1, 2025
Featured New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions December 1, 2025
Featured Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040 November 13, 2025
Featured Cardiol Therapeutics’ Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases November 5, 2025
Biotech BioNxt Reports “Intention to Grant” Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies November 4, 2025
Biotech BioNxt Reports “Readiness to Grant” Patent Notification from the Eurasian Patent Organization October 30, 2025
Search
biotechnology
February 3, 2026
February 3, 2026
January 28, 2026
December 1, 2025
December 1, 2025
November 13, 2025
November 5, 2025
November 4, 2025
October 30, 2025
October 29, 2025
